Large-scale testing (Phase 3)Ended earlyNCT03191526What this trial is testingKW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)Who this might be right forHTLV-1 Associated Myelopathy Kyowa Kirin Co., Ltd. 66
Not applicableLooking for participantsNCT03011541What this trial is testingStem Cell Ophthalmology Treatment Study IIWho this might be right forRetinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more MD Stem Cells 500
Early research (Phase 1)Looking for participantsNCT06680037What this trial is testingAssess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersWho this might be right forB-cell Mediated Autoimmune Disorders TG Therapeutics, Inc. 100
Post-approval studies (Phase 4)Study completedNCT00304265What this trial is testingPost-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis VaccineWho this might be right forPertussisDiphtheriaTetanus+1 more Sanofi Pasteur, a Sanofi Company 215
Testing effectiveness (Phase 2)Ended earlyNCT00871741What this trial is testingFeasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.Who this might be right forTetanusPoliomyelitisNeisseria Meningitidis+4 more GlaxoSmithKline 16
Not applicableStudy completedNCT05840055What this trial is testingACT with NMOSD Patients and Caregivers Pilot StudyWho this might be right forNMO Spectrum Disorder Thomas Jefferson University 43
Large-scale testing (Phase 3)Study completedNCT02094833What this trial is testingDTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsWho this might be right forDiphtheriaTetanusPertussis+3 more Sanofi Pasteur, a Sanofi Company 310
Testing effectiveness (Phase 2)Study completedNCT02040636What this trial is testingStudy of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated PoliomyelitisWho this might be right forPertussisTetanusDiphtheria+2 more Sanofi Pasteur, a Sanofi Company 277
Large-scale testing (Phase 3)WithdrawnNCT01549847What this trial is testingA Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis SyndromeWho this might be right forPostpoliomyelitis Syndrome Biolab Sanus Farmaceutica
Testing effectiveness (Phase 2)Study completedNCT00970307What this trial is testingImmunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of AgeWho this might be right forTetanusDiphtheriaHaemophilus Influenzae Type b+4 more GlaxoSmithKline 421
Not applicableStudy completedNCT05178264What this trial is testingTransverse Myelitis Related to SARS-CoV-2 VaccinesWho this might be right forVaccine Adverse Reaction University Hospital, Caen 580
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06618196What this trial is testingStudy to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeWho this might be right forDiphtheriaTetanusPertussis+3 more LG Chem 336
Large-scale testing (Phase 3)Ended earlyNCT01892345What this trial is testingControlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)Who this might be right forNeuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder Alexion Pharmaceuticals, Inc. 143
Large-scale testing (Phase 3)Active Not RecruitingNCT05346354What this trial is testingEfficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSDWho this might be right forNeuromyelitis Optica Spectrum Disorder Alexion Pharmaceuticals, Inc. 12
Post-approval studies (Phase 4)Study completedNCT01031303What this trial is testingImmunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of AgeWho this might be right forDiphtheriaTetanusPertussis+1 more Sanofi 123
Large-scale testing (Phase 3)Study completedNCT02434770What this trial is testingImmunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis VaccineWho this might be right forPoliomyelitis PATH 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT07184840What this trial is testingEculizumab For the Acute Attack of Neuromyelitis Optica Spectrum DisorderWho this might be right forNeuromyelitis Optica Spectrum Disorder Attack Tianjin Medical University General Hospital 110
Large-scale testing (Phase 3)Study completedNCT03025750What this trial is testingSafety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of AgeWho this might be right forPoliomyelitis Statens Serum Institut 800
Large-scale testing (Phase 3)Study completedNCT02428491What this trial is testingImmunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After BirthWho this might be right forDiphtheriaTetanusPertussis+3 more Sanofi Pasteur, a Sanofi Company 354
Not applicableUnknownNCT05249595What this trial is testingUltrasound Imaging Based Sensing of Human Ankle Motion Intent and Control Strategies for Ankle AssistanceWho this might be right forIncomplete Spinal Cord InjuryTransverse Myelitis North Carolina State University 25